Compare Brevis (BREV) vs Injective (INJ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Brevis vs Injective — how do they compare? Brevis trades at Rp1,181 (market cap Rp294,94M, Rp179,96M 24h volume), while Injective trades at Rp75,948 (market cap Rp7,68T, Rp1,11T 24h volume). The key difference: Injective is far larger — about 26039.2× Brevis's market cap, and Brevis's supply is capped (250M / 1B BREV (25%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Brevis for 8 Days and Injective for 37 Days on average.
| BREV | INJ | |
|---|---|---|
Market Cap | Rp294,94M | Rp7,68T |
Volume (24h) | Rp179,96M | Rp1,11T |
Circulating Supply | 250M / 1B BREV (25%) | 100M INJ |
Typical Hold Time | 8 Days | 37 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Brevis (BREV) is trading at Rp1,215.88 with a market cap of Rp304.38 million, showing a bearish technical signal as moving averages indicate strong selling pressure while oscillators remain neutral. The current price sits just below the pivot point of Rp1,219, with immediate support at Rp1,203 and resistance at Rp1,237. No recent protocol updates or ecosystem news are available, and the token has a low circulation rate of 25% with a max supply of 1 million tokens.
Overall outlook is cautious due to bearish technicals and limited liquidity. Key opportunities include potential rebounds from oversold RSI levels, but major risks involve low trading volume, high volatility, and lack of recent development activity, making it susceptible to price swings.
Injective (INJ) is currently trading at Rp75,554 with a market cap of Rp7.49T, exhibiting a bearish technical signal as indicated by moving averages. The asset trades below its pivot point of Rp82,186, with key support at Rp81,456 and resistance at Rp82,576. Recent on-chain data shows an average hold time of 37 days, suggesting moderate holding behavior.
The overall outlook is cautious due to bearish technical indicators and neutral oscillators. Key opportunities lie in potential rebounds from support levels, while major risks include high volatility and the absence of recent significant protocol updates. Investors should monitor trading volume and broader crypto market trends closely.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Brevis
Brevis is a verifiable computing platform that enables scalable, trustless computation across blockchain, data, and AI systems. It allows complex programs and data queries to run off-chain and be verified on-chain using zero-knowledge proofs, delivering significantly lower costs and latency while preserving security and trustlessness.
Read more on BREV →About Injective
Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →
